5. Infections
5.6. COVID-19 infection
Total Formulary
NIRMATRELVIR RITONAVIR (PAXLOVID) (tablets)
Restrictions:
Restricted to use in patients with increased risk for progression to severe COVID-19 in accordance with current NHSGGC prescribing guidance for COVID-19.

SOTROVIMAB (infusion)
Restrictions:
Restricted to use in accordance with current NHSGGC prescribing guidance for COVID-19 for patients with increased risk for progression to severe COVID-19 where nirmatrelvir and ritonavir is contraindicated or unsuitable.

TOCILIZUMAB (injection)
Restrictions:
Restricted to use in accordance with current NHSGGC prescribing guidance for COVID-19.